3,336
Views
27
CrossRef citations to date
0
Altmetric
Editorial

Aldosterone receptor blockers spironolactone and canrenone: two multivalent drugs

, , , &

Bibliography

  • Doggrell SA, Brown L. The spironolactone renaissance. Expert Opin Investig Drugs 2001;10(5):943-54
  • Pitt B. Effect of aldosterone blockade in patients with systolic left ventricular dysfunction: implications of the RALES and EPHESUS studies. Mol Cell Endocrinol 2004;217:53-8
  • De Simone G, Chinali M, Mureddu GF, et al. Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study. Nutr Metab Cardiovasc Dis 2011;21(10):783-91
  • Ouzounian M, Hassan A, Cox JL, et al. The effect of spironolactone use on heart failure mortality: a population-based study. J Card Fail 2007;13(3):165-9
  • Derosa G, Bonaventura A, Bianchi L, et al. Effects of canrenone in patients with metabolic syndrome. Expert Opin Pharmacother 2013;14(16):2161-9
  • Armanini D, Castello R, Scaroni C, et al. Treatment of polycystic ovary syndrome with spironolactone plus licorice. Eur J Obstet Gynecol Reprod Biol 2007;131(1):61-7
  • Armanini D, Bordin L, Donà G, et al. Polycystic ovary syndrome: implications of measurement of plasma aldosterone, renin activity and progesterone. Steroids 2012;77(6):655-8
  • Armanini D, Karbowiak I, Goi A, et al. In-vivo metabolites of spironolactone and potassium canrenoate: determination of potential anti-androgenic activity by a mouse kidney cytosol receptor assay. Clin Endocrinol (Oxf) 1985;23:341-7
  • Andriulli A, Arrigoni A, Gindro T, et al. Canrenone and androgen receptor-active materials in plasma of cirrhotic patients during long-term K-canrenoate or spironolactone therapy. Digestion 1989;44(3):155-62
  • Bordin L, Donà G, Sabbadin C, et al. Human red blood cells alterations in primary aldosteronism. J Clin Endocrinol Metab 2013;98(6):2494-501
  • Schjoedt KJ, Andersen S, Rossing P, et al. Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nefropathy is associated with enhanced decline in glomerular filtration rate. Diabetologia 2004;47:1936-9
  • Fogari R, Derosa G, Zoppi A, et al. Comparative effect of canrenone or hydrochlorothiazide addition to valsartan/amlodipine combination on urinary albumin excretion in well-controlled type 2 diabetic hypertensive patients with microalbuminuria. Expert Opin Pharmacother 2014;15(4):453-9
  • Ma J, Albornoz F, Yu Chang et al. Differing effects of mineralocorticoid receptor-dependent and -independent potassium-sparing diuretics on fibrinolytic balance. Hypertension 2005;46:313-20
  • Armanini D, Strasser T, Weber PC. Characterization of aldosterone binding sites in circulating human mononuclear leukocytes. Am J Physiol 1985;248:E388-90
  • Calò LA, Zaghetto F, Pagnin E, et al. Effect of aldosterone and glycyrrhetinic acid on the protein expression of PAI-1 and p22(phox) in human mononuclear leukocytes. J Clin Endocrinol Metab 2004;89:1973-6
  • Fiore C, Sartorato P, Pagnin E, et al. Effect of canrenone and amiloride on the prooxidative effect induced by aldosterone in human mononuclear leukocytes in vitro. J Endocrinol Invest 2009;32:895-8
  • Seley H. Anticortisol action of aldosterone. Science 1955;121:368-9

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.